/
/
Technologie CRISPR/Cas9 dans la restauration de l'expression de la dystrophine chez les progéniteurs musculaires dérivés de l'iPSC
A subscription to JoVE is required to view this content. Sign in or start your free trial.
8,148 Views
•
07:44 min
•
September 14, 2019
DOI:
Read Article
Cite this Article
Jin, Y., Shen, Y., Su, X., Weintraub, N., Tang, Y. CRISPR/Cas9 Technology in Restoring Dystrophin Expression in iPSC-Derived Muscle Progenitors. J. Vis. Exp. (151), e59432, doi:10.3791/59432 (2019).
Copy